Related Experiment Video
Updated: Aug 19, 2026
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
Recurrent rhabdomyosarcoma after 25 years: a possible association with estrogen and progestogen therapy
M Zacharin1, K Waters, C W Chow
1Department of Endocrinology, Royal Children's Hospital, Melbourne, Victoria, Australia.
Purpose:
We describe a patient with a late recurrence of rhabdomyosarcoma and review the relevant literature.
Patient And Methods:
Recurrent rhabdomyosarcoma occurred in a young woman 25 years after initial presentation, with the onset of symptoms 3 months after commencing hormonal replacement therapy with estrogen and progestogen. The primary and recurrent tumors were immunocytochemically identical. The primary tumor was steroid receptor negative but the recurrent tumor was estrogen and progesterone receptor positive.
Discussion:
Estrogen priming can stimulate synthesis of progesterone receptors which may modulate mitotic activity, which suggests a functional role for receptor positive cells in modulating cell growth when sex hormone primed, with a possible tumor induction role of sex hormone replacement therapy.
Conclusion:
The late tumor recurrence may have been induced by estrogen and progestogen treatment.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...